Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Leases (2022 - 2026)

Fulcrum Therapeutics (FULC) has 5 years of Leases data on record, last reported at $3.9 million in Q1 2026.

  • On a quarterly basis, Leases fell 27.65% to $3.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.9 million, a 27.65% decrease, with the full-year FY2025 number at $4.2 million, down 25.39% from a year prior.
  • Leases reached $3.9 million in Q1 2026 per FULC's latest filing, down from $4.2 million in the prior quarter.
  • Over the last five years, Leases for FULC hit a ceiling of $10.4 million in Q1 2022 and a floor of $3.9 million in Q1 2026.
  • A 5-year average of $7.0 million and a median of $6.7 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: dropped 17.17% in 2023, then decreased 27.65% in 2026.
  • Tracing FULC's Leases over 5 years: stood at $9.1 million in 2022, then decreased by 20.82% to $7.2 million in 2023, then dropped by 20.79% to $5.7 million in 2024, then fell by 25.39% to $4.2 million in 2025, then decreased by 8.98% to $3.9 million in 2026.
  • Business Quant data shows Leases for FULC at $3.9 million in Q1 2026, $4.2 million in Q4 2025, and $4.6 million in Q3 2025.